Drug Profile
YM 40220
Latest Information Update: 19 Jun 2001
Price :
$50
*
At a glance
- Originator Yamanouchi
- Class Antibacterials; Cephalosporins
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 19 Jun 2001 No-Development-Reported for Bacterial infections in Japan (Parenteral)
- 01 Nov 1994 Preclinical development for Bacterial infections in Japan (Parenteral)